155 related articles for article (PubMed ID: 34935141)
1. Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers.
Buters TP; Hameeteman PW; Jansen IME; van Hindevoort FC; Ten Voorde W; Grievink HW; Schoonakker M; de Kam ML; Gilroy DW; Feiss G; Rissmann R; Jansen MAA; Burggraaf J; Moerland M
Clin Pharmacol Ther; 2022 Apr; 111(4):964-971. PubMed ID: 34935141
[TBL] [Abstract][Full Text] [Related]
2. Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers.
Buters TP; Hameeteman PW; Jansen IME; van Hindevoort FC; Ten Voorde W; Florencia E; Osse M; de Kam ML; Grievink HW; Schoonakker M; Patel AA; Yona S; Gilroy DW; Lubberts E; Damman J; Feiss G; Rissmann R; Jansen MAA; Burggraaf J; Moerland M
Br J Clin Pharmacol; 2022 Feb; 88(2):680-690. PubMed ID: 34293819
[TBL] [Abstract][Full Text] [Related]
3. Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
Assil S; Buters TP; Hameeteman PW; Hallard C; Treijtel N; Niemeyer-Van der Kolk T; de Kam ML; Florencia EFIII; Prens EP; van Doorn MBA; Rissmann R; Klarenbeek NB; Jansen MAA; Moerland M
Front Immunol; 2023; 14():1197650. PubMed ID: 37545524
[TBL] [Abstract][Full Text] [Related]
4. The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers.
Jodl SJ; Ten Voorde W; Klein S; Wagenfeld A; Zollmann FS; Feldmüller M; Klarenbeek NB; de Bruin DT; Jansen MAA; Rissmann R; Rohde B; Moerland M
Clin Transl Sci; 2024 Mar; 17(3):e13771. PubMed ID: 38511583
[TBL] [Abstract][Full Text] [Related]
5. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
[TBL] [Abstract][Full Text] [Related]
6. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide.
Carbone M; Conrotto D; Carrozzo M; Broccoletti R; Gandolfo S; Scully C
Oral Dis; 1999 Jan; 5(1):44-9. PubMed ID: 10218041
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of oral corticosteroids and phosphodiesterase-4 inhibitor on the acute inflammation induced by inhaled lipopolysaccharide in human.
Michel O; Dentener M; Cataldo D; Cantinieaux B; Vertongen F; Delvaux C; Murdoch RD
Pulm Pharmacol Ther; 2007; 20(6):676-83. PubMed ID: 17045826
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo.
Cole ZA; Clough GF; Church MK
Br J Pharmacol; 2001 Jan; 132(1):286-92. PubMed ID: 11156588
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.
van der Vleuten CJ; Snijders CG; de Jong EM; van de Kerkhof PC
Skin Pharmacol; 1996; 9(6):355-65. PubMed ID: 9055356
[TBL] [Abstract][Full Text] [Related]
10. Clobetasol propionate foam, 0.05%.
Melian EB; Spencer CM; Jarvis B
Am J Clin Dermatol; 2001; 2(2):89-92; discussion 93. PubMed ID: 11705308
[TBL] [Abstract][Full Text] [Related]
11. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
[TBL] [Abstract][Full Text] [Related]
12. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
Katz HI; Lindholm JS; Weiss JS; Shavin JS; Morman M; Bressinck R; Cornell R; Pariser DM; Pariser RJ; Weng W
Clin Ther; 1995; 17(3):390-401. PubMed ID: 7585843
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
Lebwohl M; Sherer D; Washenik K; Krueger GG; Menter A; Koo J; Feldman SR
Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
[TBL] [Abstract][Full Text] [Related]
15. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
Feldman SR; Koo JY; Johnson LA; Preston NJ
Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
Maloney JM; Morman MR; Stewart DM; Tharp MD; Brown JJ; Rajagopalan R
Int J Dermatol; 1998 Feb; 37(2):142-4. PubMed ID: 9542676
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical steroid on the actions of vasoconstrictor and vasodilator peptides in human skin.
Goldsmith P; Bunker C; Leslie T; Foreman J; Dowd PM
Skin Pharmacol; 1996; 9(5):289-97. PubMed ID: 8990503
[TBL] [Abstract][Full Text] [Related]
18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
19. HPA-suppressive effects of aqueous clobetasol propionate in the treatment of patients with oral lichen planus.
Gonzalez-Moles MA; Scully C
J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1055-9. PubMed ID: 20158585
[TBL] [Abstract][Full Text] [Related]
20. Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation.
Duteil L; Queille C; Poncet M; Ortonne JP; Czernielewski J
Clin Exp Dermatol; 1990 May; 15(3):195-9. PubMed ID: 2364573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
